Pneumocystis pneumonia (PCP): a life-threatening opportunistic infection
Pneumocystis jirovecii is a common, unculturable fungus that causes Pneumocystis pneumonia (PCP). PCP symptoms are broad and non-specific (commonly presents with fever, cough, and difficulty breathing) which makes diagnosing the infection difficult.1,2 With COVID-19 posing a considerable threat for immunocompromised patients, commonalities between COVID-19 and P. jirovecii hinder their differentiation; symptomatic patients may be handled as having COVID-19 and, consequently, experience delays in necessary treatment.3,4
- 30-40% of people diagnosed with PCP have human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS).5
- Mortality rates are decreasing for HIV patients; however, rates remain significantly higher in non-HIV patients with PCP, with an average of 30.6%.6
Timely detection of PCP is crucial to help optimise patient outcomes; however, this presents certain challenges.
Microscopy-based detection methods pose a risk of overlooking P. jirovecii as they can yield false-negative results due to the low fungal burden typical for PCP in non-HIV-infected immunocompromised individuals.4
Employment of highly sensitive and reliable diagnostic methods in your laboratory is crucial to tackle this pulmonary tract infection.
Are you confident that P. jirovecii can be reliably detected in your laboratory?
A reliable option to test for unculturable Pneumocystis jirovecii on the BD MAX™ System
With the BD MAX™ System, you can run a real-time PCR for P. jirovecii from bronchopulmonary samples and help ensure timely detection of this opportunistic fungal pathogen.1,2
Ensure timely detection of this opportunistic fungal pathogen. VIASURE Pneumocystis jirovecii Real Time PCR Detection Kit for BD MAX™ System has been designed for the qualitative detection of P. jirovecii DNA in respiratory samples (bronchoalveolar lavage).
BD MAX™ System is equipped to integrate easily P. jirovecii testing in your molecular workflow.
The ability to test for other respiratory pathogens from the same VIASURE line in the same rack or even on the same unitised reagent strip can overcome challenges of non-specific symptoms and improve your workflow efficiency.
With a risk of potentially fatal PCP, doctors rely on reliable testing from your laboratory to get the timely diagnostics they require.
Consolidate your molecular testing to the BD MAX™ System and discover new respiratory assays
Extended respiratory menu on the BD MAX™ System
Greater versatility with new respiratory assays on the BD MAX™ System
BD Respiratory Viral Panel for BD MAX™ System (SARS-CoV2, Flu A, Flu B, RSV)
Give 4 results from 1 specimen in a single run
VIASURE Bordetella Real Time PCR Detection Kit for BD MAX™ System*
Detect and differentiate between three Bordetella species
The innovation of the BD MAX™ System offers you a fully integrated, automated real-time PCR benchtop platform with the possibility of running simultaneously its broad menu of molecular in vitro diagnostics (IVDs) and open-system tests.**
- Less than 1.5 minutes hands-on time per sample7,8
- 24 patient results in an average of 2.5 hours8
- 96 samples per 8-hour shift8
Its automated workflow reduces manual tasks to achieve rapid, reliable results and facilitates off-hour testing, helping to offset molecular testing costs.***7,9
